Yeast Beta‑Glucan Market to Nearly Double by 2034: Science‑Backed Immunity for Modern Supplements

The yeast beta-glucan market is projected to nearly double by 2034 — from ~$264M in 2026 to ~$498M, an 8.2% CAGR. Why? Immunity remains the #1 reason consumers buy supplements, and brands are moving beyond generic formulas toward science-backed ingredients with real mechanism stories. That's where yeast beta-glucan (1,3/1,6) fits perfectly.

Immunity Is Top Priority for Pet Parents: Yeast Beta‑Glucan for Science‑Backed Functional Pet Treats

Pet parents now read ingredient labels like their own supplement bottles — and immunity has moved to the top of the list. Big CPG moving into premium wellness (hello, P&G × Thorne) shows the same logic reaching the pet aisle: consumers want functional treats backed by science, not just clever marketing. ️ That's where yeast beta-gluc

The potential impact of yeast beta-glucan on inflammation in the human body is a topic of great interest and ongoing research

Inflammation is a natural response of the immune system to various stimuli, such as infections, injuries, or toxins. While acute inflammation is a necessary part of the healing process, chronic inflammation can contribute to the development of various diseases, including autoimmune disorders, cardiovascular diseases, and certain types of cancer. Ye